“…In vaccinated adults, sex-related differences have been observed in immunogenicity and clinical effectiveness for influenza (Wang et al ., 2002; Cook et al ., 2006; Hui et al ., 2006; Couch et al ., 2007; Nichol et al ., 2007; Engler et al ., 2008; Falsey et al ., 2009; Klein et al ., 2010c, 2012; Talaat et al ., 2010; Khurana et al ., 2012; Furman et al ., 2014), pneumococcal polysaccharide (Sankilampi et al ., 1996; Wagner et al ., 2003; Brandao et al ., 2004; Cook et al ., 2007; Goldblatt et al ., 2009; Soneji & Metlay, 2011; Wiemken et al ., 2014), hepatitis A and B (reviewed in Cook, 2008; Klein et al ., 2010a), tetanus (Marvell & Parish, 1940), diphtheria (Hasselhorn et al ., 1997), measles (Green et al ., 1994), meningococcal (Edwards et al ., 2008; Krasnicka, 2010), yellow fever (Monath et al ., 2002; Pfister et al ., 2005; Veit et al ., 2009), rabies (Briggs et al ., 2000; Banga et al ., 2014), smallpox (Kennedy et al ., 2009), Venezuelan equine encephalitis (Pittman et al ., 1996), brucella (Rhodes et al ., 1969), and HSV2 vaccine (Corey et al ., 1999; Stanberry et al ., 2002). Yet distinct documentation on sex-specific responses in probands of advanced age is extremely scarce.…”